DGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleDGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleQiagen-Aktie leicht im Plus
Die Aktie von Qiagen notiert am Dienstag etwas fester. Das Wertpapier kostete zuletzt 41,72 Euro. Für die Qiagen-Aktie steht gegenwärtig ein Kursplus 0,68 Prozent zu Buche. Die Aktie verteuerte sic...
View ArticleErfolgsgen fürs Depot: Mit Genomik-Aktien wie Illumina, Qiagen, Invitae,...
DNA-Sequenzierung, also die Bestimmung des genauen Bauplans unterschiedlicher DNA-Stränge auf molekularer Ebene, hat die biologische Wissenschaft revolutioniert und die Ära der Genomik eingeleitet....
View ArticleDGAP-DD: QIAGEN N.V. (english)
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 03.03.2022 / 22:05 The issuer is solely responsible f...
View ArticleErfolgsgen fürs Depot: Mit Genomik-Aktien wie Illumina, Qiagen, Invitae,...
DNA-Sequenzierung, also die Bestimmung des genauen Bauplans unterschiedlicher DNA-Stränge auf molekularer Ebene, hat die biologische Wissenschaft revolutioniert und die Ära der Genomik eingeleitet....
View ArticleDGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleDGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleDGAP-DD: QIAGEN N.V. (english)
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 18.03.2022 / 22:03 The issuer is solely responsible f...
View ArticleDGAP-DD: QIAGEN N.V. (english)
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 18.03.2022 / 22:03 The issuer is solely responsible f...
View ArticleQIAGEN N.V.: QIAGEN erreicht mit 100 Millionen durchgeführten...
Meilenstein am Welttuberkulosetag bestätigt Bluttest als Goldstandard im weltweiten Kampf gegen die Krankheit Präzise Tests können dabei helfen, jährlich 1,5 Millionen Todesfälle aufgrund von Tube...
View ArticleQIAGEN N.V.: QIAGEN Reaches Milestone With 100 Million QuantiFERON Tests Used...
On World TB Day, milestone confirms blood test as gold standard in global fight against the disease Accurate testing can help prevent 1.5 million TB deaths annually QIAGEN expands QuantiFERON fran...
View ArticleAktie von Qiagen läuft heute schlechter
Am Aktienmarkt notiert die Qiagen-Aktie aktuell etwas leichter. Das Wertpapier kostete zuletzt 44,20 Euro. Heute hat sich im Wertpapierhandel das Wertpapier von Qiagen zwischenzeitlich um 0,65 Proz...
View ArticleDGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleDGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleDGAP-DD: QIAGEN N.V. (english)
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 25.03.2022 / 22:03 The issuer is solely responsible f...
View ArticleBiotech Report: Qiagen und Vita34 gesucht, MorphoSys und Evotec konsolidieren
(shareribs.com) Frankfurt / New York 28.03.2022 - Biotech-Aktien zeigen sich zum Wochenauftakt uneinheitlich. Im deutschen Handel klettern unter anderem Qiagen und Vita34, während es für MorphoSys ...
View ArticleDGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleDGAP-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG...
DGAP Voting Rights Announcement: QIAGEN N.V. QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution ...
View ArticleUnser Robot findet: Qiagen, HelloFresh, RWE und weitere Aktien auffällig
Eine Radarauswahl aus unserem neuen Börsenbrief: http://www.boerse-social.com/gabb. Unter http://www.boerse-social.com/radar bekommt man die jeweils tagesaktuelle Radar-Liste (z.B. der Auszug unten...
View Article